Establishment Revenue Per Share vs Total Revenue Analysis
ESTA Stock | USD 52.83 3.33 6.73% |
Establishment Labs financial indicator trend analysis is much more than just examining Establishment Labs latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Establishment Labs is a good investment. Please check the relationship between Establishment Labs Revenue Per Share and its Total Revenue accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Revenue Per Share vs Total Revenue
Revenue Per Share vs Total Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Establishment Labs Revenue Per Share account and Total Revenue. At this time, the significance of the direction appears to have totally related.
The correlation between Establishment Labs' Revenue Per Share and Total Revenue is 0.99. Overlapping area represents the amount of variation of Revenue Per Share that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Establishment Labs Holdings, assuming nothing else is changed. The correlation between historical values of Establishment Labs' Revenue Per Share and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Revenue Per Share of Establishment Labs Holdings are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Revenue Per Share i.e., Establishment Labs' Revenue Per Share and Total Revenue go up and down completely randomly.
Correlation Coefficient | 0.99 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Revenue Per Share
The amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding.Total Revenue
Total revenue comprises all receipts Establishment Labs generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Most indicators from Establishment Labs' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Establishment Labs current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. The current year's Tax Provision is expected to grow to about 3.4 M, whereas Selling General Administrative is forecasted to decline to about 74 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 85.4M | 106.6M | 107.0M | 58.1M | Total Revenue | 126.7M | 161.7M | 165.2M | 92.0M |
Establishment Labs fundamental ratios Correlations
Click cells to compare fundamentals
Establishment Labs Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Establishment Labs fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 20.5M | 23.3M | 24.0M | 24.5M | 25.6M | 21.8M | |
Total Assets | 116.5M | 156.4M | 139.5M | 211.1M | 268.6M | 150.6M | |
Short Long Term Debt Total | 48.1M | 51.8M | 53.8M | 178.7M | 192.2M | 201.8M | |
Other Current Liab | 11.8M | 14.0M | 16.2M | 16.5M | 12.9M | 14.5M | |
Total Current Liabilities | 23.2M | 25.9M | 31.9M | 39.0M | 57.2M | 30.6M | |
Total Stockholder Equity | 39.6M | 75.0M | 50.7M | (8.2M) | 18.4M | 29.4M | |
Other Liab | 5.5M | 3.8M | 3.1M | 1.6M | 1.5M | 1.4M | |
Net Tangible Assets | 35.7M | 70.3M | 45.9M | (13.3M) | (15.2M) | (14.5M) | |
Property Plant And Equipment Net | 16.4M | 18.8M | 20.9M | 54.8M | 80.6M | 84.6M | |
Current Deferred Revenue | 785K | 1.2M | 769K | 1.7M | 1.8M | 1.5M | |
Net Debt | 10.5M | (32.8M) | 391K | 112.3M | 152.2M | 159.8M | |
Retained Earnings | (127.1M) | (165.2M) | (206.4M) | (281.6M) | (360.1M) | (342.1M) | |
Accounts Payable | 10.4M | 9.7M | 14.5M | 20.0M | 41.6M | 43.7M | |
Cash | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
Non Current Assets Total | 20.7M | 24.1M | 26.3M | 61.2M | 93.7M | 98.4M | |
Non Currrent Assets Other | 368K | 664K | 558K | 1.3M | 4.7M | 4.9M | |
Other Assets | 368K | 664K | 558K | 1.3M | 1.5M | 785.7K | |
Cash And Short Term Investments | 37.7M | 84.5M | 53.4M | 66.4M | 40.0M | 47.6M | |
Net Receivables | 22.8M | 19.1M | 24.4M | 35.4M | 46.9M | 25.6M | |
Common Stock Total Equity | 147.7M | 213.5M | 219.7M | 223.6M | 257.2M | 156.9M | |
Liabilities And Stockholders Equity | 116.5M | 156.4M | 139.5M | 211.1M | 268.6M | 150.6M | |
Non Current Liabilities Total | 53.7M | 55.5M | 56.9M | 180.3M | 193.1M | 202.8M | |
Capital Surpluse | 21.2M | 26.7M | 36.6M | 49.9M | 57.4M | 60.3M | |
Inventory | 28.7M | 23.2M | 28.4M | 36.6M | 79.9M | 83.9M | |
Other Current Assets | 1.3M | 2.6M | 2.6M | 11.5M | 8.0M | 4.6M | |
Other Stockholder Equity | 18.4M | 23.9M | 33.7M | 47.1M | 60.9M | 63.9M | |
Total Liab | 76.9M | 81.4M | 88.8M | 219.2M | 250.2M | 262.8M | |
Property Plant And Equipment Gross | 16.4M | 18.8M | 20.9M | 54.8M | 96.9M | 101.8M | |
Total Current Assets | 95.8M | 132.3M | 113.3M | 149.9M | 174.9M | 112.4M | |
Accumulated Other Comprehensive Income | 691K | 2.9M | 3.7M | 2.7M | 2.0M | 1.5M | |
Non Current Liabilities Other | 336K | 2.3M | 2.4M | 175.5M | 147K | 139.7K | |
Short Term Debt | 258K | 948K | 402K | 688K | 773K | 734.4K | |
Intangible Assets | 3.4M | 4.1M | 4.4M | 4.6M | 8.0M | 4.6M | |
Common Stock | 147.7M | 213.5M | 219.7M | 223.6M | 315.6M | 180.7M | |
Property Plant Equipment | 16.4M | 16.2M | 20.9M | 51.1M | 58.8M | 61.7M | |
Long Term Debt | 48.1M | 49.8M | 51.9M | 175.5M | 188.7M | 198.2M | |
Net Invested Capital | 87.8M | 124.8M | 102.6M | 175.5M | 207.1M | 127.1M | |
Net Working Capital | 72.6M | 106.4M | 81.4M | 110.9M | 117.8M | 87.1M |
Pair Trading with Establishment Labs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Establishment Labs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Establishment Labs will appreciate offsetting losses from the drop in the long position's value.Moving together with Establishment Stock
0.74 | CI | Cigna Corp | PairCorr |
0.62 | EW | Edwards Lifesciences Corp Earnings Call This Week | PairCorr |
Moving against Establishment Stock
0.89 | EKSO | Ekso Bionics Holdings | PairCorr |
0.88 | VERO | Venus Concept Financial Report 20th of May 2024 | PairCorr |
0.86 | FLGT | Fulgent Genetics | PairCorr |
0.85 | DRIO | DarioHealth Corp Earnings Call This Week | PairCorr |
0.83 | OM | Outset MedicalInc Trending | PairCorr |
The ability to find closely correlated positions to Establishment Labs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Establishment Labs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Establishment Labs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Establishment Labs Holdings to buy it.
The correlation of Establishment Labs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Establishment Labs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Establishment Labs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Establishment Labs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Establishment Labs Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for Establishment Stock analysis
When running Establishment Labs' price analysis, check to measure Establishment Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Establishment Labs is operating at the current time. Most of Establishment Labs' value examination focuses on studying past and present price action to predict the probability of Establishment Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Establishment Labs' price. Additionally, you may evaluate how the addition of Establishment Labs to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments |
Is Establishment Labs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Establishment Labs. If investors know Establishment will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Establishment Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.07) | Revenue Per Share 6.451 | Quarterly Revenue Growth (0.28) | Return On Assets (0.17) | Return On Equity (15.38) |
The market value of Establishment Labs is measured differently than its book value, which is the value of Establishment that is recorded on the company's balance sheet. Investors also form their own opinion of Establishment Labs' value that differs from its market value or its book value, called intrinsic value, which is Establishment Labs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Establishment Labs' market value can be influenced by many factors that don't directly affect Establishment Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Establishment Labs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Establishment Labs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Establishment Labs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.